Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism

The clinical investigation of psychedelic medicines has blossomed over the last 5 years. Data from a Phase 3 industry trial and a multicenter Phase 2 industry trial, in addition to multiple early phase investigator-initiated and industry trials, have now been published in peer-reviewed journals. Thi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neuropsychopharmacology (New York, N.Y.) N.Y.), 2024-01, Vol.49 (1), p.96-103
Hauptverfasser:	Mitchell, Jennifer M, Anderson, Brian T
Format:	Artikel
Sprache:	eng
Schlagworte:	Alcohol Clinical trials Drug use Hallucinogens Hallucinogens - pharmacology Hallucinogens - therapeutic use Ketamine LSD Lysergic acid diethylamide Methadone Multicenter Studies as Topic Narcotics Psychedelic drugs Psychotherapy Serotonin Substance abuse treatment Substance use disorder
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!